4.7 Article

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave

Journal

ANNALS OF THE RHEUMATIC DISEASES
Volume 81, Issue 12, Pages 1742-1749

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/ard-2022-222954

Keywords

Autoimmune Diseases; Covid-19; Vaccination

Categories

Funding

  1. National Institutes of Health Ruth L. Kirschstein Institutional National Research Service Award [T32 AR007530]
  2. Rheumatology Research Foundation Scientist Development Award
  3. NIH/NIAMS [K23 AR073334, R03 AR078938, R01 AR077607, P30 AR070253, P30 AR072577]
  4. Llura Gund Award for Rheumatoid Arthritis Research and Care
  5. R. Bruce and Joan M. Mickey Research Scholar Fund

Ask authors/readers for more resources

This study investigated temporal trends in the incidence and severity of COVID-19 among patients with systemic autoimmune rheumatic diseases. The proportion of patients with severe COVID-19 has decreased over time, particularly during the most recent time periods, including the initial Omicron wave. Unvaccinated individuals had a higher proportion of severe cases compared to vaccinated individuals.
Objectives To investigate temporal trends in incidence and severity of COVID-19 among patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through the initial Omicron wave. Methods We conducted a retrospective cohort study investigating COVID-19 outcomes among patientswith SARD systematically identified to have confirmed COVID-19 from 1 March 2020 to 31 January 2022 at Mass General Brigham. We tabulated COVID-19 counts of total and severe cases (hospitalisations or deaths) and compared the proportion with severe COVID-19 by calendar period and by vaccination status. We used logistic regression to estimate the ORs for severe COVID-19 for each period compared with the early COVID-19 period (reference group). Results We identified 1449 patients with SARD with COVID-19 (mean age 58.4 years, 75.2% female, 33.9% rheumatoid arthritis). There were 399 (28%) cases of severe COVID-19. The proportion of severe COVID-19 outcomes declined over calendar time (p for trend <0.001); 46% of cases were severe in the early COVID-19 period (1 March 2020-30 June 2020) vs 15% in the initial Omicron wave (17 December 2021-31 January 2022; adjusted OR 0.29, 95% CI 0.19 to 0.43). A higher proportion of those unvaccinated were severe compared with not severe cases (78% vs 60%). Conclusions The proportion of patients with SARD with severe COVID-19 has diminished since early in the pandemic, particularly during the most recent time periods, including the initial Omicron wave. Advances in prevention, diagnosis and treatment of COVID-19 may have improved outcomes among patients with SARD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available